This site is intended for health professionals only!

Published on 2 June 2014

Share this story:
Twitter
LinkedIn

Actavis brings escitalopram to market

Actavis has launched escitalopram tablets, which further strengthens Actavis’ portfolio of over 750 generic medicines across a wide variety of therapy areas.

Escitalopram is indicated for the treatment of major depressive episodes, panic disorders, with or without agoraphobia, social anxiety disorder and obsessive compulsive disorder (OCD).

Actavis has launched escitalopram tablets, which further strengthens Actavis’ portfolio of over 750 generic medicines across a wide variety of therapy areas.

Escitalopram is indicated for the treatment of major depressive episodes, panic disorders, with or without agoraphobia, social anxiety disorder and obsessive compulsive disorder (OCD).

Actavis is offering escitalopram tablets in 5mg, 10mg and 20mg strength packs of 28 tablets. All products are available through major wholesalers or directly from the Actavis Telemarketing team (freephone: 0800 731 0370; fax: 0800 731 0380).

Jonathan Wilson, Executive Director UK, commented: “Actavis continues to be first to market offering the high-quality pharmaceuticals expected of a leading UK manufacturer with over 175 years’ experience in healthcare. We are committed to providing pharmacy with increased choice and competitively priced medicines.”



Most read




Latest Issue

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Share this story:
Twitter
LinkedIn